You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Correction: Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

 

Online download statistics by month:

Online download statistics by month: November 2022 to January 2026

AbstractFullPdf
Nov 2022021841
Dec 202206014
Jan 202305914
Feb 20230345
Mar 20230186
Apr 20230105
May 20230106
Jun 20230112
Jul 2023075
Aug 2023096
Sep 2023071
Oct 2023064
Nov 20230111
Dec 2023094
Jan 20240166
Feb 20240164
Mar 202401528
Apr 202402112
May 20240112
Jun 20240154
Jul 20240265
Aug 20240114
Sep 20240158
Oct 20240145
Nov 20240104
Dec 20240144
Jan 2025073
Feb 2025043
Mar 20250112
Apr 20250211
May 20250106
Jun 20250163
Jul 2025010
Jan 2026010
Total0724218